Nagoya University
21 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma (NCT06983210) | Nagoya University | 2025-05-01 |
| Deep Learning-based Artificial Intelligence for the Diagnosis of Small Bowel Obstruction (NCT06481358) | Nagoya University | 2022-09-01 |
| Investigator-initiated Clinical Trial of MIKE-1 (NCT05064618) | Nagoya University | 2021-08-23 |
| The Clinical Trial of ADR-001 for IgA Nephropathy (NCT04342325) | Nagoya University | 2020-06-15 |
| The Clinical Trial of CL2020 Cells for Neonatal Hypoxic Ischemic Encephalopathy (NCT04261335) | Nagoya University | 2020-03-04 |
| The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies (NCT03864185) | Nagoya University | 2019-03-28 |
Track Nagoya University automatically
Every clearance here is in the API, with alerts when new ones post.